NRX Pharmaceuticals, Inc. (NRXP) › Total AssetsNRX Pharmaceuticals, Inc. (NRXP) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $69.57M2018: $70.80M2019: $32.07M2020: $2.94M2021: $32.73M2022: $25.82M2023: $7.32M2024: $3.65M2025: $12.96M$12.96M2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$12.96M+254.9%2024$3.65M-50.1%2023$7.32M-71.7%2022$25.82M-21.1%2021$32.73M+1012.9%2020$2.94M-90.8%2019$32.07M-54.7%2018$70.80M+1.8%2017$69.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share